{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:35:29Z","timestamp":1785814529703,"version":"3.56.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.beem.2014.08.009","type":"journal-article","created":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T13:15:54Z","timestamp":1409577354000},"page":"127-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Bridging the age spectrum of neurodegenerative storage diseases"],"prefix":"10.1016","volume":"29","author":[{"given":"Barry","family":"Boland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.beem.2014.08.009_bib1","first-page":"104","article-title":"Newborn screening for lysosomal storage disorders","volume":"30","author":"Meikle","year":"1999","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10545-010-9093-7","article-title":"The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations","volume":"33","author":"Poupetova","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"issue":"9","key":"10.1016\/j.beem.2014.08.009_bib3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrm2745","article-title":"Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function","volume":"10","author":"Saftig","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1\u20133","key":"10.1016\/j.beem.2014.08.009_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbalip.2004.08.008","article-title":"Intracellular trafficking of Niemann-Pick C proteins 1 and 2: obligate components of subcellular lipid transport","volume":"1685","author":"Liscum","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"10.1016\/j.beem.2014.08.009_bib5","doi-asserted-by":"crossref","first-page":"22347","DOI":"10.1074\/jbc.M400643200","article-title":"Defective endoplasmic reticulum-resident membrane protein CLN6 affects lysosomal degradation of endocytosed arylsulfatase A","volume":"279","author":"Heine","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00109-005-0001-9","article-title":"The role of vesicular transport in ABCA1-dependent lipid efflux and its connection with NPC pathways","volume":"84","author":"Boadu","year":"2006","journal-title":"J\u00a0Mol Med"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1755-148X.2009.00558.x","article-title":"Griscelli syndrome: a model system to study vesicular trafficking","volume":"22","author":"Van Gele","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"issue":"48","key":"10.1016\/j.beem.2014.08.009_bib8","doi-asserted-by":"crossref","first-page":"16795","DOI":"10.1073\/pnas.0405905101","article-title":"Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi\/beige cells","volume":"101","author":"Huynh","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1083\/jcb.201003053","article-title":"Exocytosis of acid sphingomyelinase by wounded cells promotes endocytosis and plasma membrane repair","volume":"189","author":"Tam","year":"2010","journal-title":"J\u00a0Cell Biol"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.tins.2013.11.006","article-title":"Stuck in traffic: an emerging theme in diseases of the nervous system","volume":"37","author":"Neefjes","year":"2014","journal-title":"Trends Neurosci"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4161\/auto.6259","article-title":"Neurodegenerative lysosomal disorders: a continuum from development to late age","volume":"4","author":"Nixon","year":"2008","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrm2217","article-title":"Lysosomes: fusion and function","volume":"8","author":"Luzio","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1042\/BST0381413","article-title":"Endosome-lysosome fusion","volume":"38","author":"Luzio","year":"2010","journal-title":"Biochem Soc Trans"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib14","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006361","article-title":"The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease","volume":"2","author":"Ihara","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nrm2330","article-title":"Membrane lipids: where they are and how they behave","volume":"9","author":"van Meer","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib16","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1074\/jbc.M505888200","article-title":"Phosphatidylserine in addition to phosphatidylethanolamine is an in\u00a0vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16","volume":"281","author":"Sou","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1515\/BC.2001.059","article-title":"Localization of lysobisphosphatidic acid-rich membrane domains in late endosomes","volume":"382","author":"Kobayashi","year":"2001","journal-title":"Biol Chem"},{"issue":"43","key":"10.1016\/j.beem.2014.08.009_bib18","doi-asserted-by":"crossref","first-page":"32451","DOI":"10.1074\/jbc.M607281200","article-title":"Saposin A mobilizes lipids from low cholesterol and high bis(monoacylglycerol)phosphate-containing membranes: patient variant Saposin A lacks lipid extraction capacity","volume":"281","author":"Locatelli-Hoops","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"7","key":"10.1016\/j.beem.2014.08.009_bib19","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1194\/jlr.M003822","article-title":"Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion","volume":"51","author":"Abdul-Hammed","year":"2010","journal-title":"J\u00a0Lipid Res"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/YCO.0000000000000041","article-title":"Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?","volume":"27","author":"Panza","year":"2014","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200412022","article-title":"Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice","volume":"169","author":"Komatsu","year":"2005","journal-title":"J\u00a0Cell Biol"},{"issue":"7020","key":"10.1016\/j.beem.2014.08.009_bib22","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature03029","article-title":"The role of autophagy during the early neonatal starvation period","volume":"432","author":"Kuma","year":"2004","journal-title":"Nature"},{"issue":"7095","key":"10.1016\/j.beem.2014.08.009_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"issue":"5\u20136","key":"10.1016\/j.beem.2014.08.009_bib24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.mam.2006.08.009","article-title":"Neuronal macroautophagy: from development to degeneration","volume":"27","author":"Boland","year":"2006","journal-title":"Mol Aspects Med"},{"issue":"6798","key":"10.1016\/j.beem.2014.08.009_bib25","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/35022595","article-title":"Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice","volume":"406","author":"Tanaka","year":"2000","journal-title":"Nature"},{"issue":"27","key":"10.1016\/j.beem.2014.08.009_bib26","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","article-title":"Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease","volume":"28","author":"Boland","year":"2008","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.beem.2014.08.009_bib27","doi-asserted-by":"crossref","first-page":"141083","DOI":"10.1155\/2013\/141083","article-title":"Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases","volume":"2013","author":"Gouras","year":"2013","journal-title":"Int J Cell Biol"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnen\/64.2.113","article-title":"Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study","volume":"64","author":"Nixon","year":"2005","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"14","key":"10.1016\/j.beem.2014.08.009_bib29","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1523\/JNEUROSCI.5167-03.2004","article-title":"Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain","volume":"24","author":"Takahashi","year":"2004","journal-title":"J\u00a0Neurosci"},{"issue":"21","key":"10.1016\/j.beem.2014.08.009_bib30","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","article-title":"Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing","volume":"18","author":"Wang","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib31","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1073\/pnas.0908953107","article-title":"Alzheimer's-related endosome dysfunction in down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition","volume":"107","author":"Jiang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib32","first-page":"691","article-title":"Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-beta protein precursor transgenic mice","volume":"34","author":"Choi","year":"2013","journal-title":"J\u00a0Alzheimer's Dis"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib33","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1073\/pnas.0712309105","article-title":"Elevated globotriaosylsphingosine is a hallmark of Fabry disease","volume":"105","author":"Aerts","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1022436928925","article-title":"Twenty five years of the \u201cpsychosine hypothesis\u201d: a personal perspective of its history and present status","volume":"23","author":"Suzuki","year":"1998","journal-title":"Neurochem Res"},{"issue":"27","key":"10.1016\/j.beem.2014.08.009_bib35","doi-asserted-by":"crossref","first-page":"20423","DOI":"10.1074\/jbc.R110.134452","article-title":"Common and uncommon pathogenic cascades in lysosomal storage diseases","volume":"285","author":"Vitner","year":"2010","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1083\/jcb.153.2.429","article-title":"Identification of a molecular target of psychosine and its role in globoid cell formation","volume":"153","author":"Im","year":"2001","journal-title":"J\u00a0Cell Biol"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm.3449","article-title":"RIPK3 as a potential therapeutic target for Gaucher's disease","volume":"20","author":"Vitner","year":"2014","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib38","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1023\/A:1010991420942","article-title":"Psychosine is as potent an inducer of cell death as C6-ceramide in cultured fibroblasts and in MOCH-1 cells","volume":"26","author":"Tohyama","year":"2001","journal-title":"Neurochem Res"},{"issue":"11","key":"10.1016\/j.beem.2014.08.009_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0962-8924(00)01847-X","article-title":"Jamming the endosomal system: lipid rafts and lysosomal storage diseases","volume":"10","author":"Simons","year":"2000","journal-title":"Trends Cell Biol"},{"issue":"25","key":"10.1016\/j.beem.2014.08.009_bib40","doi-asserted-by":"crossref","first-page":"26167","DOI":"10.1074\/jbc.M311591200","article-title":"Accumulation of glycosphingolipids in Niemann-Pick C disease disrupts endosomal transport","volume":"279","author":"te Vruchte","year":"2004","journal-title":"J\u00a0Biol Chem"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10545-010-9109-3","article-title":"Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice","volume":"33","author":"te Vruchte","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.beem.2014.08.009_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.1998.tb09668.x","article-title":"Use of BODIPY-labeled sphingolipids to study membrane traffic along the endocytic pathway","volume":"845","author":"Pagano","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.beem.2014.08.009_bib43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-0854.2000.011101.x","article-title":"Membrane traffic in sphingolipid storage diseases","volume":"1","author":"Pagano","year":"2000","journal-title":"Traffic"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1039\/C3MT00308F","article-title":"Altered transition metal homeostasis in Niemann-Pick disease, type C1","volume":"6","author":"Hung","year":"2014","journal-title":"Metallomics"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2009.01.015","article-title":"Critical role of iron in the pathogenesis of the murine gangliosidoses","volume":"34","author":"Jeyakumar","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0197-4580(98)00052-9","article-title":"Evolution in the conceptualization of dementia and Alzheimer's disease: Greco-Roman period to the 1960s","volume":"19","author":"Berchtold","year":"1998","journal-title":"Neurobiol Aging"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/mds.25420","article-title":"The history of parkinsonism: descriptions in ancient Indian medical literature","volume":"28","author":"Ovallath","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.beem.2014.08.009_bib48","series-title":"Fabry disease","article-title":"History of lysosomal storage diseases: an overview","author":"Mehta","year":"2006"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1042\/bj0600604","article-title":"Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue","volume":"60","author":"De Duve","year":"1955","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib50","first-page":"161","article-title":"Cajal's contributions to the study of Alzheimer's disease","volume":"12","author":"Garcia-Marin","year":"2007","journal-title":"J\u00a0Alzheimer's Dis"},{"key":"10.1016\/j.beem.2014.08.009_bib51","series-title":"Das senile und prasenile Irresein. Psychiatrie: Ein Lehrbuch fur Studierende und Arzte","first-page":"533","author":"Kraepelin","year":"1910"},{"issue":"1\u20133","key":"10.1016\/j.beem.2014.08.009_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbalip.2004.08.011","article-title":"Consequences of NPC1 and NPC2 loss of function in mammalian neurons","volume":"1685","author":"Walkley","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib53","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0344-0338(11)80422-X","article-title":"Lysosomal storage diseases in adults","volume":"190","author":"Rapola","year":"1994","journal-title":"Pathol Res Pract"},{"issue":"4\u20135","key":"10.1016\/j.beem.2014.08.009_bib54","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000112160","article-title":"Biochemical basis of late-onset neurolipidoses","volume":"13","author":"Conzelmann","year":"1991","journal-title":"Dev Neurosci"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib55","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2010.10.007","article-title":"A\u00a0monozygotic twin pair with highly discordant Gaucher phenotypes","volume":"46","author":"Biegstraaten","year":"2011","journal-title":"Blood Cells Mol Dis"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"QJM"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib57","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib58","first-page":"1401","article-title":"Early-versus late-onset Alzheimer's disease: more than age alone","volume":"19","author":"Koedam","year":"2010","journal-title":"J\u00a0Alzheimer's Dis"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib59","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(12)70307-1","article-title":"A\u00a0presenilin 1 mutation in the first case of Alzheimer's disease","volume":"12","author":"Muller","year":"2013","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.beem.2014.08.009_bib60","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1083\/jcb.201201076","article-title":"Lysosomal calcium homeostasis defects, not proton pump defects, cause endo-lysosomal dysfunction in PSEN-deficient cells","volume":"198","author":"Coen","year":"2012","journal-title":"J\u00a0Cell Biol"},{"issue":"17","key":"10.1016\/j.beem.2014.08.009_bib62","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1523\/JNEUROSCI.23-17-06788.2003","article-title":"App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome","volume":"23","author":"Cataldo","year":"2003","journal-title":"J\u00a0Neurosci"},{"issue":"7","key":"10.1016\/j.beem.2014.08.009_bib63","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.bbadis.2014.04.007","article-title":"Neuropathological role of PI3K\/Akt\/mTOR axis in down syndrome brain","volume":"1842","author":"Perluigi","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib64","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/hmg\/3.4.569","article-title":"Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region","volume":"3","author":"Chartier-Harlin","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and Abeta in Alzheimer's disease: accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib66","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib67","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1523\/JNEUROSCI.2425-12.2013","article-title":"The pro-neurotrophin receptor sortilin is a major neuronal apolipoprotein E receptor for catabolism of amyloid-beta peptide in the brain","volume":"33","author":"Carlo","year":"2013","journal-title":"J\u00a0Neurosci"},{"issue":"18","key":"10.1016\/j.beem.2014.08.009_bib68","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","article-title":"Genome-wide analysis of genetic loci associated with Alzheimer disease","volume":"303","author":"Seshadri","year":"2010","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib69","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","article-title":"Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease","volume":"43","author":"Hollingworth","year":"2011","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib70","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1001\/archpsyc.61.5.518","article-title":"Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: the cache county study","volume":"61","author":"Khachaturian","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib71","first-page":"25","article-title":"Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease","volume":"12","author":"Anglade","year":"1997","journal-title":"Histol Histopathol"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib72","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1750-3639.2003.tb00478.x","article-title":"Localization of phosphorylated ERK\/MAP kinases to mitochondria and autophagosomes in lewy body diseases","volume":"13","author":"Zhu","year":"2003","journal-title":"Brain Pathol"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib73","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","article-title":"Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions","volume":"35","author":"Chu","year":"2009","journal-title":"Neurobiol Dis"},{"issue":"37","key":"10.1016\/j.beem.2014.08.009_bib74","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib75","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.beem.2014.08.009_bib76","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib77","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/emmm.201200215","article-title":"Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease","volume":"4","author":"Sanchez-Danes","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.beem.2014.08.009_bib78","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/B978-0-12-385883-2.00011-4","article-title":"Molecular insights into Parkinson's disease","volume":"107","author":"Rochet","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib79","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4161\/auto.7.1.13933","article-title":"Lysosomal membrane permeabilization in Parkinson disease","volume":"7","author":"Vila","year":"2011","journal-title":"Autophagy"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn3068","article-title":"Fighting neurodegeneration with rapamycin: mechanistic insights","volume":"12","author":"Bove","year":"2011","journal-title":"Nat Rev Neurosci"},{"issue":"17","key":"10.1016\/j.beem.2014.08.009_bib81","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.beem.2014.08.009_bib82","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib84","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J\u00a0Cell Biol"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib85","doi-asserted-by":"crossref","first-page":"e9313","DOI":"10.1371\/journal.pone.0009313","article-title":"Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy","volume":"5","author":"Crews","year":"2010","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib86","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080928","article-title":"Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein","volume":"175","author":"Yu","year":"2009","journal-title":"Am J Pathol"},{"issue":"21","key":"10.1016\/j.beem.2014.08.009_bib87","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","article-title":"Lewy body-like alpha-synuclein aggregates resist degradation and impair macroautophagy","volume":"288","author":"Tanik","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib88","article-title":"Loss of leucine-rich repeat kinase 2 causes age-dependent bi-phasic alterations of the autophagy pathway","volume":"7","author":"Tong","year":"2012","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib89","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1471-4159.2008.05217.x","article-title":"Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells","volume":"105","author":"Plowey","year":"2008","journal-title":"J\u00a0Neurochem"},{"issue":"7097","key":"10.1016\/j.beem.2014.08.009_bib90","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04779","article-title":"Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin","volume":"441","author":"Clark","year":"2006","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.beem.2014.08.009_bib91","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1093\/hmg\/ddr048","article-title":"Broad activation of the ubiquitin-proteasome system by Parkin is critical for mitophagy","volume":"20","author":"Chan","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"19","key":"10.1016\/j.beem.2014.08.009_bib92","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","article-title":"ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease","volume":"68","author":"Di Fonzo","year":"2007","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib93","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/humu.21527","article-title":"Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism","volume":"32","author":"Park","year":"2011","journal-title":"Hum Mutat"},{"issue":"10","key":"10.1016\/j.beem.2014.08.009_bib94","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beem.2014.08.009_bib95","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib96","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1212\/WNL.52.2.392","article-title":"Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease","volume":"52","author":"Nance","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.beem.2014.08.009_bib97","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.biocel.2004.03.009","article-title":"Aging as a catabolic malfunction","volume":"36","author":"Terman","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib98","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1017\/S1041610213001749","article-title":"What should we do if we were wrong and Alzheimer was right?","volume":"26","author":"Breitner","year":"2014","journal-title":"Int Psychogeriatr"},{"issue":"6103","key":"10.1016\/j.beem.2014.08.009_bib99","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.1222942","article-title":"The science of resilience: implications for the prevention and treatment of depression","volume":"338","author":"Southwick","year":"2012","journal-title":"Science"},{"issue":"7493","key":"10.1016\/j.beem.2014.08.009_bib100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature13163","article-title":"REST and stress resistance in ageing and Alzheimer's disease","volume":"507","author":"Lu","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.beem.2014.08.009_bib101","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu Rev Med"},{"issue":"8","key":"10.1016\/j.beem.2014.08.009_bib102","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12033-014-9771-z","article-title":"Applications of TALENs and CRISPR\/Cas9 in human cells and their potentials for gene therapy","volume":"56","author":"Niu","year":"2014","journal-title":"Mol Biotechnol"},{"issue":"457","key":"10.1016\/j.beem.2014.08.009_bib103","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr"},{"issue":"26","key":"10.1016\/j.beem.2014.08.009_bib104","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.beem.2014.08.009_bib105","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0165-6147(03)00158-5","article-title":"A\u00a0contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity","volume":"24","author":"Fan","year":"2003","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"10.1016\/j.beem.2014.08.009_bib106","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1016\/S0021-9258(17)37202-2","article-title":"N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis","volume":"269","author":"Platt","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib107","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1358\/dot.2006.42.1.937457","article-title":"Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders","volume":"42","author":"Lachmann","year":"2006","journal-title":"Drugs Today"},{"issue":"1","key":"10.1016\/j.beem.2014.08.009_bib108","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s40265-013-0164-6","article-title":"Miglustat: a review of its use in niemann-pick disease type C","volume":"74","author":"Lyseng-Williamson","year":"2014","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.beem.2014.08.009_bib109","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcmd.2008.11.002","article-title":"Promising results of the chaperone effect caused by imino sugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease","volume":"42","author":"Sanchez-Olle","year":"2009","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"10.1016\/j.beem.2014.08.009_bib110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00126839-200607060-00003","article-title":"A\u00a0chaperone-mediated approach to enzyme enhancement as a therapeutic option for the lysosomal storage disorders","volume":"7","author":"Pastores","year":"2006","journal-title":"Drugs R D"},{"key":"10.1016\/j.beem.2014.08.009_bib111","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2741\/e368","article-title":"Peripheral cholesterol, metabolic disorders and Alzheimer's disease","volume":"4","author":"Ledesma","year":"2012","journal-title":"Front Biosci Elite Ed"},{"issue":"12","key":"10.1016\/j.beem.2014.08.009_bib112","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/WNR.0b013e32832e4b9d","article-title":"Gangliosides determine the amyloid pathology of Alzheimer's disease","volume":"20","author":"Oikawa","year":"2009","journal-title":"Neuroreport"},{"issue":"20","key":"10.1016\/j.beem.2014.08.009_bib113","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0861-04.2004","article-title":"A\u00a0seed for Alzheimer amyloid in the brain","volume":"24","author":"Hayashi","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.beem.2014.08.009_bib114","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1038\/ncomms5028","article-title":"iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis","volume":"5","author":"Schondorf","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib115","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/jnc.12672","article-title":"Inhibition of glucosylceramide synthase stimulates autophagy flux in neurons","volume":"129","author":"Shen","year":"2014","journal-title":"J\u00a0Neurochem"},{"issue":"5","key":"10.1016\/j.beem.2014.08.009_bib116","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2011.07.030","article-title":"Autophagy and aging","volume":"146","author":"Rubinsztein","year":"2011","journal-title":"Cell"},{"issue":"5939","key":"10.1016\/j.beem.2014.08.009_bib117","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A\u00a0gene network regulating lysosomal biogenesis and function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.beem.2014.08.009_bib118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","article-title":"Transcriptional activation of lysosomal exocytosis promotes cellular clearance","volume":"21","author":"Medina","year":"2011","journal-title":"Dev Cell"},{"issue":"9","key":"10.1016\/j.beem.2014.08.009_bib119","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nm.1851","article-title":"Restoration of chaperone-mediated autophagy in aging liver improves cellular maintenance and hepatic function","volume":"14","author":"Zhang","year":"2008","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.beem.2014.08.009_bib120","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/j.cell.2013.11.037","article-title":"Declining NAD(+) induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging","volume":"155","author":"Gomes","year":"2013","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.beem.2014.08.009_bib121","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.25469","article-title":"SNCA: major genetic modifier of age at onset of Parkinson's disease","volume":"28","author":"Brockmann","year":"2013","journal-title":"Mov Disord"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X14001006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X14001006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:49:24Z","timestamp":1761497364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X14001006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":121,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1521690X14001006"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2014.08.009","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the age spectrum of neurodegenerative storage diseases","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2014.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}